HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jingxuan Pan Selected Research

pyrvinium (Vankin)

11/2020Erratum: Anthelmintic pyrvinium pamoate blocks Wnt/β-catenin and induces apoptosis in multiple myeloma cells.
4/2018Anthelmintic pyrvinium pamoate blocks Wnt/β-catenin and induces apoptosis in multiple myeloma cells.
10/2017Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jingxuan Pan Research Topics

Disease

39Neoplasms (Cancer)
12/2021 - 05/2005
18BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2021 - 03/2009
12Uveal melanoma
12/2021 - 03/2016
9Neoplasm Metastasis (Metastasis)
01/2022 - 06/2012
9Leukemia
01/2022 - 01/2014
5Systemic Mastocytosis
10/2014 - 01/2007
4Oncogene Addiction
10/2021 - 05/2010
4Multiple Myeloma
11/2020 - 08/2013
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
10/2014 - 01/2007
3Pdgfra-Associated Chronic Eosinophilic Leukemia
10/2021 - 01/2014
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2015 - 06/2012
3Carcinogenesis
01/2015 - 10/2005
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2015 - 01/2007
3Hypereosinophilic Syndrome (Loeffler Endocarditis)
11/2014 - 11/2009
3Anaplastic Thyroid Carcinoma
08/2007 - 06/2005
2Breast Neoplasms (Breast Cancer)
10/2021 - 02/2010
2Carcinoma (Carcinomatosis)
10/2021 - 07/2010
2Esophageal Squamous Cell Carcinoma
06/2018 - 01/2017
2Necrosis
06/2018 - 09/2017
2Myeloid Leukemia (Leukemia, Myelocytic)
04/2018 - 02/2013
2Myeloproliferative Disorders (Myeloproliferative Disorder)
12/2017 - 05/2010
2Mast-Cell Leukemia (Leukemia, Mast Cell)
05/2014 - 01/2010
2Osteosarcoma (Osteogenic Sarcoma)
07/2010 - 10/2008
1Cardiotoxicity
01/2020
1Malaria
01/2018
1Enterobiasis
10/2017
1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
04/2015
1Disease Progression
05/2014
1Hyperglycemia
06/2012

Drug/Important Bio-Agent (IBA)

16Imatinib Mesylate (Gleevec)FDA Link
12/2021 - 03/2009
10CateninsIBA
10/2021 - 01/2014
10Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2005
7Tyrosine Kinase InhibitorsIBA
09/2021 - 04/2012
7Pharmaceutical PreparationsIBA
01/2020 - 02/2010
6Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2021 - 01/2007
5NiclosamideFDA Link
01/2020 - 03/2010
5triptolideIBA
06/2010 - 03/2009
5Farnesyltranstransferase (Farnesyltransferase)IBA
10/2008 - 05/2005
4celastrol methyl esterIBA
12/2021 - 05/2010
4bcr-abl Fusion ProteinsIBA
01/2018 - 05/2010
4Paclitaxel (Taxol)FDA LinkGeneric
02/2010 - 06/2005
3Histone Deacetylase InhibitorsIBA
01/2022 - 03/2016
3ponatinibIBA
10/2021 - 01/2014
3N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
10/2021 - 04/2012
3AnthelminticsIBA
11/2020 - 02/2017
3pyrvinium (Vankin)FDA Link
11/2020 - 10/2017
3GSK-2816126IBA
01/2020 - 01/2017
3Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 10/2005
3Reactive Oxygen Species (Oxygen Radicals)IBA
06/2012 - 05/2005
3manumycinIBA
10/2008 - 06/2005
2Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2022 - 10/2021
2salinomycinIBA
03/2021 - 11/2019
2S116836IBA
01/2020 - 07/2014
2Phosphotransferases (Kinase)IBA
01/2017 - 05/2014
2tenovin-6IBA
03/2016 - 04/2015
2Sirtuin 1IBA
03/2016 - 04/2015
2Growth Factor ReceptorsIBA
11/2014 - 11/2009
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
12/2010 - 01/2010
2NF-kappa B (NF-kB)IBA
05/2010 - 03/2010
2Oncogene Proteins (Oncogene Protein)IBA
11/2009 - 09/2005
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2022
1Collagen Type I (Type I Collagen)IBA
12/2021
1human PRMT2 proteinIBA
10/2021
1Factor V (Coagulation Factor V)IBA
10/2021
1X-Box Binding Protein 1IBA
09/2021
1Small Interfering RNA (siRNA)IBA
01/2020
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2019
1GTP Phosphohydrolases (GTPases)IBA
01/2019
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019
1Cytochromes c (Cytochrome c)IBA
04/2018
1pevonedistatIBA
01/2018
1ArtesunateIBA
01/2018
1artemisinin (artemisinine)IBA
01/2018
1Antimalarials (Antimalarial Agents)IBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2017
1palbociclibIBA
01/2017
1Cyclin-Dependent Kinase 4IBA
01/2017
1CyclinsIBA
01/2017
1MethyltransferasesIBA
10/2016
1Histone Deacetylases (Histone Deacetylase)IBA
03/2016
1CytokinesIBA
08/2015
1Cytarabine (Cytosar-U)FDA LinkGeneric
04/2015
1Etoposide (VP 16)FDA LinkGeneric
04/2015
13-deazaneplanocinIBA
01/2015
1Histones (Histone)IBA
01/2015
1Dasatinib (BMS 354825)FDA Link
01/2014
1nilotinibFDA Link
01/2014
1S- 4- (4- ethyl- 7- isopropyl- 2,5,8,12- tetraoxo- 9- oxa- 3,6,13,18- tetraazabicyclo(13,2,1)octadec- 1- en- 10- yl)but- 3- enyl octanethioateIBA
01/2014
1Alkylating AgentsIBA
08/2013
1TOR Serine-Threonine KinasesIBA
08/2013
1Bendamustine HydrochlorideFDA Link
08/2013
1EverolimusFDA Link
08/2013
1DCC-2036IBA
01/2013
1AnthracyclinesIBA
06/2012
1InsulinsIBA
06/2012
1ThiazolidinedionesIBA
06/2012

Therapy/Procedure

6Therapeutics
01/2018 - 05/2010
6Drug Therapy (Chemotherapy)
01/2017 - 02/2010
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2018 - 06/2010
1Liver Transplantation
11/2019